ANALYST-UPGRADE ·Filed Aug 12, 2026

MRK

Merck & Co., Inc.
BULLISH
Impact 4/10
Processed1mo ago SECanalyst-MRK-daiwacap-20260812
Daiwa Capital double upgrade: Neutral → Outperform
Actionable Insight ▲ Bullish

The double upgrade from a moderately accurate firm is a bullish catalyst, but insider selling and high short interest create a contrarian tension. Traders should watch for price confirmation above $130.42 before adding long exposure, with a stop below $125.

DirectionBullish
Latest settled — T+20d ⚠ clustered
MRK ▲ +8.87% at T+20d
LONG call ✓ call won +8.87% · α vs SPY +10.77% · entry $132.92 → $144.71
Next anchor: T+60d in 5w
Latest observation: T+34 +8.41% FF3 residual α
Entry anchored
Aug 12, 11:38 AM ET
via 1-min bar
T+1d
+1.98%
call +1.98% · α +1.28%
$135.55
settled 7w ago
T+5d
+14.51%
call +14.51% · α +14.95%
$152.20
settled 6w ago
T+20d
+8.87%
call +8.87% · α +10.77%
$144.71
settled 22d ago
T+60d
—
call — · α —
—
in 5w

Price Chart

Loading chart...

Executive Summary

Daiwa Capital double-upgraded Merck & Co. (MRK) from Neutral to Outperform on August 12, 2026, raising its price target to $143 from $120, implying 9.6% upside from the current $130.42. The firm has a 52% accuracy rate on 21 calls with a 6.7% average return. Consensus is bullish: 25 of 36 analysts rate MRK Buy or Strong Buy, 11 rate Hold, and none rate Sell. The mean target is $136.85, median $141.50, with a high of $155 and low of $105. Daiwa's $143 target sits above the mean but below the median. Momentum is positive with 1 upgrade and 0 downgrades in the past 30 days, though EPS revisions have been mixed with 2 downward revisions in the current quarter. Insider selling occurred on August 5-6, with five transactions totaling ~$3.3 million, including a $1.97 million sale by Guindo Chirfi. Institutional activity is mixed, with one large add and two trims. Short interest is elevated at 56.8% of TRF volume. The double upgrade from a moderately accurate firm is a notable bullish signal, but insider selling and high short interest warrant caution.

Impact Score

Base Score
2/7
LLM Adjustment
+2
Final Score
4/10

Consensus & Targets

Buy / Strong Buy
25 (69%)
Hold
11
Sell / Strong Sell
0
Total Analysts
26
Mean PT
$136.85
Median PT
$141.50
High PT
$155.00
Low PT
$105.00
Current Price
$130.42
Implied Upside
+4.9%

Consensus is bullish: 9 Strong Buy, 16 Buy, 11 Hold, 0 Sell, 0 Strong Sell across 36 analysts. The majority (69%) rate MRK a Buy or Strong Buy, with no bearish ratings. Daiwa's Outperform aligns with the bullish consensus direction.

Current price: $130.42. Mean target: $136.85 (4.9% upside). Median: $141.50 (8.5% upside). High: $155 (18.8% upside). Low: $105 (19.5% downside). Daiwa's $143 PT is above the mean and median, implying 9.6% upside, placing it in the upper quartile of targets.

Recent Analyst Activity

DateFirmActionRatingPrice Target
2026-08-12Daiwa CapitalupgradeOutperform$143.00
2026-08-11Argus ResearchmaintainBuy$145.00
2026-08-05GuggenheimmaintainBuy$146.00
2026-07-29BarclaysmaintainOverweight$150.00
2026-07-13JP MorganmaintainOverweight$140.00
2026-07-13BMO CapitalmaintainOutperform$142.00
2026-07-13GuggenheimmaintainBuy$145.00
2026-07-09Morgan StanleymaintainEqual-Weight$113.00
2026-07-08RBC CapitalreiterateOutperform$142.00
2026-07-08Wells FargomaintainOverweight$150.00

30-day analyst activity: 1 upgrade (Daiwa), 0 downgrades. EPS revisions show a mixed trend: current quarter (0q) EPS estimates fell from $2.30 to $2.22 over 30 days with 2 downward revisions; next quarter (+1q) estimates are flat; full-year 0y estimates edged down from $2.71 to $2.74 (net 1 up, 2 down). Overall, estimates are being revised slightly lower.

Firm Track Record — Daiwa Capital

Daiwa Capital accuracy: 52% on 21 calls | avg return: 6.7%

Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 12 firms with ≥5 scored calls.

FirmAccuracyCallsAvg Returnvs Average
Deutsche Bank100%2/29.7%top tier
BMO Capital50%2/40.7%below average
Morgan Stanley43%3/72.8%below average
Wells Fargo40%2/53.8%below average
B of A Securities33%1/3-0.2%below average
Guggenheim25%1/4-7.8%below average
Truist Securities20%1/5-10.3%below average
Cantor Fitzgerald9%1/11-5.5%below average
Barclays0%0/2-7.6%below average
Berenberg0%0/211.6%below average

Daiwa Capital has a 52% accuracy rate on 21 calls with a 6.7% average return, ranking near the middle of firms covering MRK. The best-performing firm is Deutsche Bank (100% on 2 calls, 9.7% avg return). The worst is Cantor Fitzgerald (9% on 11 calls, -5.5% avg return). Daiwa's accuracy is above the median of the peer set.

Earnings Estimates

PeriodEPS Est.EPS RangeRevenueRevisions (7d)
0q$2.22$2.01 — $2.41$17.3B↑0 ↓0
+1q$1.95$1.86 — $2.08$16.9B↑0 ↓0
0y$2.74$2.62 — $2.87$67.1B↑0 ↓0
+1y$9.55$8.33 — $10.36$70.3B↑0 ↓0

Cross-Platform Signals

Insider Trades (90d)
0 buys / 5 sells
Institutional
Zurcher Kantonalbank (Zurich Cantonalbank) — add (44.7%)
Institutional
FIRST TRUST ADVISORS LP — trim (-42%)
Institutional
Clearstead Advisors, LLC — trim (-26.1%)
Short Interest
Short: 1,375,251 | Exempt: 2,579 | TRF Vol: 2,420,158 | Short Ratio: 56.8% | Off-exchange volume (dark pool + OTC)

Insider trades: 5 sales totaling ~$3.3M on Aug 5-6, including a $1.97M sale by Guindo Chirfi and $789K by Richard DeLuca. These sales oppose the bullish upgrade, creating a bearish divergence. Institutional activity is mixed: Zurich Cantonalbank added 44.7% ($190M), while First Trust Advisors trimmed 42% ($333M) and M&G trimmed 29.2% ($27M). Short interest is elevated at 56.8% of TRF volume, indicating significant bearish positioning. No congressional trades reported.

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

Report based on filing metadata.

20 reports for MRK
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+20▲ +18.67%Aug 6, 2026
Filters
Rows
Reports for MRK — sortable, filterable
TypeNow
Sep 11, 2026
21d ago
Court Ruling
NEUTRAL ★ 1/10
$143.93 $146.87▲ +2.04%▲ +2.26%$143.81 (−0.08%)
Sep 9, 2026
23d ago
Court Ruling
NEUTRAL ★ 1/10
$147.53 $144.91▼ −1.78%▼ −1.12%$143.81 (−2.52%)
Aug 27, 2026
5w ago
Court Ruling
NEUTRAL ★ 1/10
$149.54 $152.34▲ +1.87%▲ +1.60%$143.81 (−3.83%)
Aug 24, 2026
5w ago
Court Ruling
BEARISH ★ 5/10
$150.66 $147.73▲ +1.95%▲ +2.42%$143.81 (+4.55%)
Aug 20, 2026
6w ago
ANALYST-UPGRADE
MIXED ★ 5/10
$148.99 $149.54▲ +0.37%▼ −0.75%$143.81 (−3.48%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$135.84 $152.55▲ +12.30%▲ +13.67%$143.81 (+5.87%)
Aug 13, 2026
7w ago
Court Ruling
NEUTRAL ★ 3/10
$135.55 $148.99▲ +9.92%▲ +11.88%$143.81 (+6.09%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$135.55 $148.99▲ +9.92%▲ +11.88%$143.81 (+6.09%)
Aug 12, 2026
7w ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$132.92 $152.20▲ +14.51%▲ +14.95%$143.81 (+8.19%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$132.92 $152.20▲ +14.51%▲ +14.95%$143.81 (+8.19%)
Showing 10 of 20

US Market Status

Market Open — Closes in 6h 30m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 12, 2026